A major locus for hereditary prostate cancer in Finland:: localization by linkage disequilibrium of a haplotype in the HPCX region

被引:27
作者
Baffoe-Bonnie, AB
Smith, JB
Stephan, DA
Schleutker, J
Carpten, JD
Kainu, T
Gillanders, EM
Matikainen, M
Teslovich, TM
Tammela, T
Sood, R
Balshem, AM
Scarborough, SD
Xu, JF
Isaacs, WB
Trent, JM
Kallioniemi, OP
Bailey-Wilson, JE
机构
[1] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD 21224 USA
[2] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA
[3] Vanderbilt Univ, Med Ctr, Med Res Serv, VA Tennessee Valley Healthcare Syst,Dept Med, Nashville, TN 37232 USA
[4] TGEN, Phoenix, AZ 85004 USA
[5] Univ Tampere, Inst Med Technol, Canc Genet Lab, Tampere 33014, Finland
[6] Tampere Univ Hosp, Tampere 33014, Finland
[7] NHGRI, NIH, Bethesda, MD 20892 USA
[8] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland
[9] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[10] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA
[11] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA
[12] Univ Turku, VTT Tech Res Ctr Finland, Med Biotechnol Dept, Turku, Finland
关键词
D O I
10.1007/s00439-005-1306-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Prostate cancer (PRCA) is the most common cancer in males in the western world. In Finland PRCA has an age-adjusted incidence of 81.5 per 100,000. We previously reported that in Finland, the late-onset cases in families with "no-male-to-male'' (NMM) transmission of PRCA accounted for most of the linkage to the HPCX region (Xq27-28). The aim of the present study was to test for linkage disequilibrium (LD) and haplotype-sharing around marker DXS1205 between cases from hereditary prostate cancer (HPC) families and population controls. The initial allelic association was performed between 108 PRCA cases and 257 population controls genotyped for 23 markers in the Xq26-28 region. This resulted in a highly significant nominal one-sided Fisher's exact P-value of 0.0003 for allele "180'' of marker DXS1205. Subsequently, a similar level of significance was observed for the same allele for marker DXS1205 (P = 0.0002) when comparing 60 NMM cases and 257 controls. These results were still significant after Bonferroni correction for multiple testing. Fine mapping efforts included the genotyping of four additional markers D3S2390, bG82i1.9, bG82i1.1, bG82i1.0 and four single nucleotide polymorphisms ( SNPs) to augment the original markers around DXS1205. Results: Our major finding is that markers extending from "D3S2390'' to "bG82i1.0'' flank the critical locus, about 150 kb. Levin and Bertell's LD measure (delta), a guide to localization of a possible variant, was 0.42 and 0.41 for alleles of markers bG82i1.9 and DXS1205, respectively. Conclusions: In this study, the most significant haplotype comprised the three tightly linked, contiguous markers: "cen-bG82i1.9-SNP-Hap B-bG82i1.1-tel'' ["197-2-234''] among several possible haplotypes ( nominal Fisher's one-sided P=0.003). The two transcription units mapping within this interval are the LDOC1 and SPANXC genes. Positional cloning of the HPCX gene(s) is being facilitated by this exploration of the Xq26-28 region. This study represents the first report identifying a haplotype in the Xq27-28 region for an association between HPCX and X-linked prostate cancer with no-male-to-male transmission in the Finnish population.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 41 条
[1]   Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer [J].
Bergthorsson, JT ;
Johannesdottir, G ;
Arason, A ;
Benediktsdottir, KR ;
Agnarsson, BA ;
Bailey-Wilson, JE ;
Gillanders, E ;
Smith, J ;
Trent, J ;
Barkardottir, RS .
HUMAN GENETICS, 2000, 107 (04) :372-375
[2]   Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families [J].
Bochum, S ;
Paiss, T ;
Vogel, W ;
Herkommer, K ;
Hautmann, R ;
Haeussler, J .
PROSTATE, 2002, 52 (01) :12-19
[3]   Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease [J].
Botstein, D ;
Risch, N .
NATURE GENETICS, 2003, 33 (Suppl 3) :228-237
[4]  
*CANC SOC FINL, 2000, CANC SOC FINL PUBL
[5]   PCAP is the major known prostate cancer predisposing locus in families from south and west Europe [J].
Cancel-Tassin, G ;
Latil, A ;
Valéri, A ;
Mangin, P ;
Fournier, G ;
Berthon, P ;
Cussenot, O .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :135-142
[6]   Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 [J].
Carpten, J ;
Nupponen, N ;
Isaacs, S ;
Sood, R ;
Robbins, C ;
Xu, J ;
Faruque, M ;
Moses, T ;
Ewing, C ;
Gillanders, E ;
Hu, P ;
Buinovszky, P ;
Makalowska, I ;
Baffoe-Bonnie, A ;
Faith, D ;
Smith, J ;
Stephan, D ;
Wiley, K ;
Brownstein, M ;
Gildea, D ;
Kelly, B ;
Jenkins, R ;
Hostetter, G ;
Matikainen, M ;
Schleutker, J ;
Klinger, K ;
Connors, T ;
Xiang, Y ;
Wang, Z ;
De Marzo, A ;
Papadopoulos, N ;
Kallioniemi, OP ;
Burk, R ;
Meyers, D ;
Grönberg, H ;
Meltzer, P ;
Silverman, R ;
Bailey-Wilson, J ;
Walsh, P ;
Isaacs, W ;
Trent, J .
NATURE GENETICS, 2002, 30 (02) :181-184
[7]   Mapping a disease locus by allelic association [J].
Collins, A ;
Morton, NE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1741-1745
[8]   Allelic association with SNPs: Metrics, populations, and the linkage disequilibrium map [J].
Collins, A ;
Ennis, S ;
Taillon-Miller, P ;
Kwok, PY ;
Morton, NE .
HUMAN MUTATION, 2001, 17 (04) :255-262
[9]  
Cussenot O, 2001, Eur J Intern Med, V12, P11, DOI 10.1016/S0953-6205(00)00136-9
[10]   A COMPARISON OF LINKAGE DISEQUILIBRIUM MEASURES FOR FINE-SCALE MAPPING [J].
DEVLIN, B ;
RISCH, N .
GENOMICS, 1995, 29 (02) :311-322